The current SOPH market cap is 301.07M. The company's latest EPS is USD -1.2108 and P/E is -4.01.
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 40.45M | 47.56M | 62.37M |
Operating Income | -71.49M | -87.82M | -74.83M |
Net Income | -73.68M | -87.45M | -78.98M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 320.17M | 243.84M | 206.16M |
Total Liabilities | 44.77M | 43.71M | 54.71M |
Total Equity | 275.4M | 200.13M | 151.44M |
Market Cap | 301.07M |
Price to Earnings Ratio | -4.01 |
Price to Sales Ratio | 5.08 |
Price to Cash Ratio | 2.57 |
Price to Book Ratio | 2.09 |
Dividend Yield | - |
Shares Outstanding | 65.23M |
Average Volume (1 week) | 139.94k |
Average Volume (1 Month) | 126.79k |
52 Week Change | 0.12% |
52 Week High | 7.37 |
52 Week Low | 2.70 |
Spread (Intraday) | 0.42 (8.28%) |
Company Name | Sophia Genetics SA |
Address |
rue du centre 172 lausanne 1025 |
Website | https://www.sophiagenetics.com |
Industry | cmp processing,data prep svc (7374) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions